We have located links that may give you full text access.
Fast-Track Zika Vaccine Development - Is It Possible?
New England Journal of Medicine 2016 September 30
Studies have demonstrated that various Zika virus (ZIKV) vaccine constructs generate protective immune responses in mice and nonhuman primates, and two DNA ZIKV vaccine candidates have entered phase 1 human safety testing (ClinicalTrials.gov numbers, NCT01099852 and NCT02840487). ZIKV vaccine..
Full text links
Related Resources
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app